Active Ingredient(s): Teriparatide
FDA Approved: * October 4, 2019
Pharm Company: * PFENEX INC
Category: Osteoporosis

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Bonsity Overview

Teriparatide is a form of parathyroid hormone consisting of the first (N-terminus) 34 amino acids, which is the bioactive portion of the hormone. It is an effective anabolic (promoting bone formation) agent[3] used in the treatment of some forms of osteoporosis.[4] It is also occasionally used off-label to speed fracture healing. Teriparatide is identical to a portion of human parathyroid hormone (PTH) and intermittent use activates osteoblasts more than osteoc...

Read more Bonsity Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Bonsity Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 0.6mg/2.4ml (0.25mg/ml), 0.75mg/3ml (0.25mg/ml), 20mcg, 750mcg/3ml, eq 0.75mg/3ml (0.25mg/ml), eq 0.75mg/3ml(0.25mg/ml)
  • Solution: 0.62mg/2.48ml (0.25mg/ml), 0.6mg/2.4ml (0.25mg/ml), 0.75mg/3ml (0.25mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Teriparatide or a similar ingredient: (2 results)